4National Committee for clinical laboratory standards. EP9 - A Methord comparison and bias estimation using patient samples [ S ]. Wayne, PA : NCCLS. 1995. 被引量：1
5National Committee for Clinical Laboratory Standards.Method comparison and bias estimation using patientsamples;approved guideline[S].EP9-A,NCCLS,2002. 被引量：1
6Roberts WL,Sedrick R,Moulton L,et al.Evaluationof four automated high-sensitivity C-reactive proteinmethods:implications for clinical and epidemiologicalapplications[J].Clin Chem,2000,46(4):461-468. 被引量：1
7National Committee for Clinical Standards. Method comparison and bias estimation using patient samples; approved guideline-second edition [ S ]. EP9-A2, NCCI_S,2002. 被引量：1
8Hossain MA, Emara M, E1 Moselhi H, et al. Comparing measures of cystatin C in human sera by three methods [ J]. Am J Nephrol, 2009 , 29 (5) : 381-391. 被引量：1
9National Committee for Clinical Standards. Method comparison and bias estimation using patient samples; approved guideline [ S ]. EP9-A, NCCLS, 1995. 被引量：1
10International Organization for Standardization. In vitro diagnostic medical devices. Measurement of quanti- ties in biological samples. Metrological traceability of values assigned to calibrators and control materials [S]. IS017511,IS0, 2003. 被引量：1
